PGNY - Progyny, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
29.99
-3.68 (-10.93%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close33.67
Open33.67
Bid29.91 x 1400
Ask30.49 x 800
Day's Range29.60 - 34.07
52 Week Range13.29 - 36.50
Volume1,253,215
Avg. Volume798,528
Market Cap2.44B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year Results Report

    Progyny, Inc. (PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31, 2019 on Thursday, March 5, 2020, after the close of the market. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.877.883.0383 and using the passcode 2146745.

  • GlobeNewswire

    Progyny, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference

    Progyny, Inc. (PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced David Schlanger, Progyny’s Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 11:00 A.M. Pacific Time (2:00 P.M. Eastern Time). After the presentation, there will be a breakout session at 11:30 A.M. Pacific Time (2:30 P.M. Eastern Time). This event will be held in San Francisco at the Westin St. Francis.

  • GlobeNewswire

    Progyny, Inc. Announces Third Quarter 2019 Results

    Reports 120% Increase in Third Quarter Revenue to $61.2 MillionIssues Revenue Guidance of $65.0 to $66.5 Million for the Fourth Quarter of 20192019 Selling Season Concludes with.

  • GlobeNewswire

    Progyny, Inc. Announces Participation in Upcoming Investor Conference

    Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its participation in two upcoming investor conferences. David Schlanger, Progyny’s Chief Executive Officer, and Pete Anevski, President, CFO and COO, will participate in Piper Jaffray’s 31st Annual Healthcare conference on Thursday, December 5th. A live audiocast and replay of Mr. Schlanger’s fireside chat will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

  • GlobeNewswire

    Progyny, Inc. Announces Details for Its Third Quarter Results Report

    Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended September 30, 2019 on Wednesday, December 4, 2019, after the close of the market. The company will host a conference call at 5:00 P.M. Eastern Time (or 2:00 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. International participants may access the call by dialing 1.412.902.6506 and using the same passcode.

  • GlobeNewswire

    Progyny, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    NEW YORK, Oct. 29, 2019 -- Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today.

  • GlobeNewswire

    Progyny, Inc. Announces Pricing of Initial Public Offering

    NEW YORK, Oct. 24, 2019 -- Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today.